Actualités, ressources, mises à jour
Une plateforme scientifique pour vous tenir informés de nos dernières recherches et de l'actualité de notre entreprise.
Tests in vitro translationnels visant à évaluer l'efficacité d'un médicament contre la maladie d'Alzheimer et la maladie de Parkinson
Modelling neurodegenerative disease using in vitro assays Neurodegenerative drug development is held back due to the lack of appropriate models that help accelerate the pace at which novel therapeutic candidates move through the drug development pipeline. As such, in...
Test validé d'hypersensibilité de type retardé chez des souris de type sauvage ou humanisées
Delayed-type hypersensitivity (DTH) in vivo assay represents a relatively quick and useful approach for evaluating the efficacy of potential immunomodulatory or immunosuppressive compounds. By challenging the cell-mediated immune response, you obtain valuable...
Mesure validée du débit de filtration glomérulaire (DFG) par voie transdermique dans des modèles de maladies rénales
At InnoSer, we offer several readouts to assess the disease progression and the efficacy of novel targeted polycystic kidney disease (PKD) compounds. However, we understand that it remains a significant challenge to access crucial readouts that are recognized by...
Étude de cas : Modèle de psoriasis, une inflammation cutanée aiguë
Performing efficacy studies using psoriasis models Psoriasis arises due to the dysregulation of the interplay between the innate and adaptive immune system together with other compartments such as epithelium, vasculature, and cutaneous nervous system. On the cellular...
L'immunophénotypage pour évaluer l'efficacité des nouvelles immunothérapies
It is well-established that syngeneic mouse models represent a powerful tool to evaluate therapies that target the immune system. The key to understanding your immuno-modulatory compound's efficacy is to work with well-characterised models, with known growth kinetics...
Enregistrement EEG des potentiels évoqués auditifs chez des souris Fmr1 KO
July is Fragile X Syndrome (FXS) Awareness month, a time dedicated to raising awareness about this rare genetic disorder, affecting thousands of individuals worldwide. We are deeply committed to accelerating the availability of targeted therapies to improve the lives...
info@innoserlaboratories.com
Liens rapides